← 產業報告目錄

AI in Remote Patient Monitoring (RPM) Market by Component (Device: Wearable, Implantable, Portable; Software, Service), Indication (Cardiac, Neuro, Onco, Diabetes, Sleep, Mental Health), End User (Hospitals, Clinics, Payer), Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-03-04頁數 324報告編號 HIT9321

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The AI in remote patient monitoring market is projected to reach USD 8,438.5 million by 2030 from USD 1,967.7 million in 2024, at a high CAGR of 27.5% during the forecast period. Reason for growth in the AI in remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. According to US CDC about 1 in 31 hospital patients has at least one healthcare-associated infection. For instance, the University of Pittsburgh Medical Center reported that RPM devices reduced hospital readmissions by 76%. “Wearable devices is the fastest growing segment in the AI in remote patient monitoring market by devices in 2023” Wearable devices is expected to be the fastest-growing segment in the AI in remote patient monitoring market during 2023, due to the increasing acceptance of AI-enabled biosensors, smartwatches, and wearables for medical use. These devices are based on machine learning, deep learning, and continuous monitoring of vital signs, early detecting potential health issues, and supplying predictive insights. Other developments in AI-enabled ECG monitoring, glucose monitoring, and telehealth-enabling wearables are further supporting growth by increasing patient engagement and chronic disease management. For instance, in August 2024, Masimo's W1 Medical Watch received FDA 510(k) clearance to be incorporated into the Masimo SafetyNet Telemonitoring System for remote monitoring of health in real-time. “North America dominated the remote patient monitoring market in 2023.” The AI in remote patient monitoring market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the remote patient monitoring market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing trend in the chronic diseases patients suffer from and the increasing need for home healthcare solutions will also increase growth in this region's market. As of 2023, over 500 medical AI devices have undergone U.S. Food and Drug Administration (FDA) evaluation and received approval including RPM related medical devices. The break-down of primary participants is as mentioned below: • By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25% • By Designation - C-level: 35%, Director-level: 40%, and Others: 25% • By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%. Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthcare, Inc. (Japan), GE HealthCare (US), Medtronic (Ireland), AliveCor, Inc. (US), NIHON KOHDEN CORPORATION (Japan), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), Beijing Choice Electronic Tech Co. Ltd (US), Biobeat (Israel), Biotronik (Germany), and AccurKardia, Inc. (US) are some of the key players in the AI in remote patient monitoring market. • The study includes an in-depth competitive analysis of these key players in the AI in remote patient monitoring market, with their company profiles, recent developments, and key market strategies. Research Coverage This research report categorizes the AI in remote patient monitoring market by component (devices [wearable devices, implantable devices, handheld & portable devices, stationary devices]), software and services). By indication (oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement (weight management, fitness monitoring, hydration monitoring, nutritional tracking & monitoring, etc), mental health, and other indications (obstetrics, immunology, infectious diseases, ophthalmology, and others). By end user (healthcare providers [hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, long term care & assisted living facilities, home healthcare, and other healthcare providers (diagnostics & imagining centers)], healthcare payers, patients, pharmaceutical & biotechnology companies, medTech companies, and other end users (employer groups, government organizations, academic institutes, research centers, and others)), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in remote patient monitoring market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the AI in remote patient monitoring market. Competitive analysis of upcoming startups in the AI in remote patient monitoring market ecosystem is covered in this report. Reasons to buy this report: The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the AI in remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (growing telehealth and remote patient monitoring markets, rising prevalence of chronic diseases, growing adoption of mhealth apps, increased government support and favorable reimbursement policies, growing awareness about lifestyle management and home healthcare) restraints (regulatory variations across regions, shortage of skilled professionals to operate AI based tools, and data security concerns) opportunities (growing in the demand for personalized medicine, increase in the partnership and collaboration among healthcare providers and AI based companies, growing opportunities in emerging nations, hospital-at-home, and rising investment in AI based RPM solutions) challenges (issues related to accuracy due to scarcity of high quality healthcare data, reluctance among healthcare professionals to adopt AI in remote patient monitoring, and lack of interoperability) • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the AI in remote patient monitoring market • Market Development: Comprehensive information about lucrative markets – the report analyses the AI in remote patient monitoring market across varied regions. • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the AI in remote patient monitoring market • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthare, Inc. (Japan), GE HealthCare (US), Boston Scientific Corporation (US), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), NIHON KOHDEN CORPORATION (Japan), and Biotronik (Germany); among others in the AI in remote patient monitoring market
目錄 Table of Contents
1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.3 STUDY SCOPE 30 1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD 30 1.3.2 INCLUSIONS & EXCLUSIONS 31 1.3.3 YEARS CONSIDERED 32 1.3.4 CURRENCY CONSIDERED 32 1.4 STAKEHOLDERS 33 2 RESEARCH METHODOLOGY 34 2.1 RESEARCH DATA 34 2.1.1 SECONDARY DATA 35 2.1.1.1 Key sources of secondary data 35 2.1.1.2 Key data from secondary sources 35 2.1.2 PRIMARY DATA 36 2.1.2.1 Key sources of primary data 36 2.1.2.2 Objectives of primary research 36 2.1.2.3 Key data from primary sources 37 2.1.2.4 Key insights from primary experts 38 2.1.2.5 Breakdown of primary sources 39 2.2 MARKET SIZE ESTIMATION 39 2.2.1 SUPPLY-SIDE ANALYSIS 41 2.2.2 BOTTOM-UP APPROACH (END-USER ADOPTION) 43 2.2.3 TOP-DOWN APPROACH 44 2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 44 2.3 DATA TRIANGULATION 48 2.4 STUDY ASSUMPTIONS 49 2.4.1 MARKET SIZING ASSUMPTIONS 49 2.4.2 MARKET GROWTH ASSUMPTIONS 49 2.5 RISK ANALYSIS 50 2.6 RESEARCH LIMITATIONS 50 2.6.1 METHODOLOGY-RELATED LIMITATIONS 50 2.6.2 SCOPE-RELATED LIMITATIONS 50 3 EXECUTIVE SUMMARY 51   4 PREMIUM INSIGHTS 55 4.1 AI IN REMOTE PATIENT MONITORING MARKET OVERVIEW 55 4.2 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER AND REGION, 2023 56 4.3 AI IN REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC SNAPSHOT 57 4.4 AI IN REMOTE PATIENT MONITORING MARKET: DEVELOPED VS. EMERGING MARKETS 57 5 MARKET OVERVIEW 58 5.1 INTRODUCTION 58 5.2 MARKET DYNAMICS 58 5.2.1 DRIVERS 60 5.2.1.1 Expanding telehealth and remote patient monitoring markets 60 5.2.1.2 Increasing prevalence of chronic diseases 61 5.2.1.3 Focus on development and adoption of mHealth applications 61 5.2.1.4 Increased government support and favorable reimbursement policies 62 5.2.1.5 Growing awareness about lifestyle management and home healthcare 62 5.2.2 RESTRAINTS 63 5.2.2.1 Regulatory variations across regions 63 5.2.2.2 Shortage of skilled professionals to operate AI-based remote patient monitoring tools 63 5.2.2.3 Data security concerns 64 5.2.3 OPPORTUNITIES 64 5.2.3.1 Growing demand for personalized medicines and care plans 64 5.2.3.2 Increase in partnerships and collaborations among healthcare providers and AI-based companies 65 5.2.3.3 Growth opportunities in emerging economies 66 5.2.3.4 Rising investment in AI-based remote patient monitoring solutions 66 5.2.4 CHALLENGES 67 5.2.4.1 Scarcity of high-quality healthcare data and privacy concerns 67 5.2.4.2 Reluctance among healthcare professionals to adopt AI in remote patient monitoring devices 67 5.2.4.3 Lack of interoperability 68 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 68 5.4 INDUSTRY TRENDS 69 5.4.1 SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE 69 5.4.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGIES 69 5.5 ECOSYSTEM ANALYSIS 69 5.5.1 ROLE IN ECOSYSTEM 71 5.6 VALUE CHAIN ANALYSIS 72   5.7 TECHNOLOGY ANALYSIS 73 5.7.1 KEY TECHNOLOGIES 73 5.7.1.1 Wearable devices and sensors 73 5.7.1.2 AI and ML 73 5.7.1.3 Predictive analytics 74 5.7.2 COMPLEMENTARY TECHNOLOGIES 74 5.7.2.1 mHealth applications 74 5.7.2.2 Cloud computing 74 5.7.2.3 Digital health platforms 75 5.7.3 ADJACENT TECHNOLOGIES 75 5.7.3.1 Point-of-care diagnostics 75 5.7.3.2 Smart home health devices 75 5.8 TARIFF & REGULATORY ANALYSIS 76 5.8.1 TARIFF ANALYSIS 76 5.8.1.1 Tariff data for HS code 9018 76 5.8.1.2 Tariff data for HS code 9021 77 5.8.1.3 Tariff data for HS code 9022 78 5.8.2 REGULATORY FRAMEWORK 79 5.8.2.1 North America 79 5.8.2.2 Europe 80 5.8.2.3 Asia Pacific 81 5.8.2.4 Middle East & Africa 82 5.8.2.5 Latin America 82 5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 5.9 TRADE ANALYSIS 87 5.9.1 TRADE ANALYSIS FOR HSN CODE 90189099 87 5.9.1.1 Import data for HSN code 90189099 88 5.9.1.2 Export data for HSN code 90189099 88 5.9.2 TRADE ANALYSIS FOR HSN CODE 9021 89 5.9.2.1 Import data for HSN code 9021 89 5.9.2.2 Export data for HSN code 9021 89 5.9.3 TRADE ANALYSIS FOR HSN CODE 9022 90 5.9.3.1 Import data for HSN code 9022 90 5.9.3.2 Export data for HSN code 9022 90 5.10 PRICING ANALYSIS 91 5.10.1 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023 91 5.10.2 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023 92   5.11 PORTER’S FIVE FORCES ANALYSIS 93 5.11.1 INTENSITY OF COMPETITIVE RIVALRY 95 5.11.2 BARGAINING POWER OF BUYERS 95 5.11.3 THREAT OF SUBSTITUTES 95 5.11.4 THREAT OF NEW ENTRANTS 95 5.11.5 BARGAINING POWER OF SUPPLIERS 95 5.12 KEY STAKEHOLDERS & BUYING CRITERIA 96 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 96 5.12.2 KEY BUYING CRITERIA 97 5.13 PATENT ANALYSIS 97 5.13.1 PATENT PUBLICATION TRENDS 97 5.13.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS 98 5.13.3 TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET 99 5.13.4 LIST OF KEY PATENTS/PATENT APPLICATIONS 100 5.14 UNMET NEEDS & END-USER EXPECTATIONS 102 5.14.1 UNMET NEEDS 102 5.14.2 END-USER EXPECTATIONS 103 5.15 KEY CONFERENCES & EVENTS, 2025–2026 104 5.16 CASE STUDY ANALYSIS 105 5.16.1 ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING 105 5.16.2 ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS 105 5.16.3 ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY 106 5.17 INVESTMENT & FUNDING SCENARIO 107 5.18 BUSINESS MODEL ANALYSIS 107 5.18.1 SUBSCRIPTION-BASED MODELS 107 5.18.2 PLATFORM-AS-A-SERVICE MODELS 107 5.18.3 SERVICE-BASED MODELS 107 5.18.4 FREEMIUM MODELS 107 5.18.5 COLLABORATIVE ECOSYSTEM AND PARTNERSHIP MODELS 108 5.19 REIMBURSEMENT SCENARIO ANALYSIS 108 6 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT 111 6.1 INTRODUCTION 112 6.2 DEVICES 112 6.2.1 WEARABLE DEVICES 114 6.2.1.1 Rising adoption of consumer health technologies and growing trend toward preventive healthcare to drive segment 114 6.2.2 IMPLANTABLE DEVICES 115 6.2.2.1 Development of wireless communication technologies and advancements in medical devices to spur market adoption 115 6.2.3 HANDHELD & PORTABLE DEVICES 116 6.2.3.1 Rising consumer preference for home healthcare and self-monitoring to aid market growth 116 6.2.4 STATIONARY DEVICES 117 6.2.4.1 Reduced hospitalizations and improved patient outcomes through timely alerts to aid market growth 117 6.3 SOFTWARE 118 6.3.1 EFFECTIVE TRANSFORMATION OF RAW DATA TO PERSONALIZED INSIGHTS FOR PATIENTS TO AUGMENT MARKET GROWTH 118 6.4 SERVICES 119 6.4.1 INCREASING NEED FOR VALUE-BASED SPECIALIZED SERVICES TO BOOST MARKET GROWTH 119 7 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION 121 7.1 INTRODUCTION 122 7.2 ONCOLOGY 122 7.2.1 NEED FOR IMPROVED SYMPTOM MONITORING AND PERSONALIZED TREATMENT PLANS TO DRIVE MARKET 122 7.3 CARDIOLOGY 124 7.3.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH 124 7.4 NEUROLOGY 124 7.4.1 GROWING ADOPTION OF TELEMEDICINE AND RISING NEED FOR CONTINUOUS MONITORING TO AID MARKET GROWTH 124 7.5 DIABETES 125 7.5.1 HIGH ADOPTION OF AI-POWERED DEVICES FOR EFFECTIVE DIABETES MANAGEMENT TO PROPEL MARKET GROWTH 125 7.6 SLEEP DISORDERS 126 7.6.1 AI-POWERED REMOTE PATIENT MONITORING DEVICES TO ENSURE EFFECTIVE SLEEP APNEA MANAGEMENT 126 7.7 RESPIRATORY DISEASES 127 7.7.1 GROWING BURDEN OF COPD AND ASTHMA IN LOW- AND MIDDLE-INCOME COUNTRIES TO SUPPORT MARKET GROWTH 127 7.8 WELLNESS IMPROVEMENT 128 7.8.1 RISING PREVALENCE OF OBESITY AND LIFESTYLE DISEASES TO AUGMENT MARKET GROWTH 128 7.9 MENTAL HEALTH DISORDERS 129 7.9.1 AI-BASED REMOTE PATIENT MONITORING TO IMPROVE ACCESS TO MENTAL HEALTH SUPPORT AND REDUCE STIGMA OF IN-PERSON THERAPY 129 7.10 OTHER INDICATIONS 129   8 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER 131 8.1 INTRODUCTION 132 8.2 HEALTHCARE PROVIDERS 132 8.2.1 HOSPITALS 134 8.2.1.1 Rising demand for high-quality care and increasing incidence of chronic diseases to drive market 134 8.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 135 8.2.2.1 AI-driven remote patient monitoring devices to enhance postoperative care, patient safety, and recovery outcomes 135 8.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 135 8.2.3.1 Need for prolonged treatment for chronic diseases and high cost of hospital stays to fuel uptake 135 8.2.4 HOME HEALTHCARE FACILITIES 136 8.2.4.1 Increased preference for at-home treatment options to drive market 136 8.2.5 OTHER HEALTHCARE PROVIDERS 137 8.3 HEALTHCARE PAYERS 138 8.3.1 FAVORABLE REIMBURSEMENT SCENARIO FOR REMOTE PATIENT MONITORING SERVICES TO AUGMENT MARKET GROWTH 138 8.4 PATIENTS 138 8.4.1 ADVANCEMENTS IN WEARABLE DEVICES AND PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH 138 8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 139 8.5.1 AI-BASED REMOTE PATIENT MONITORING SOLUTIONS TO ASSIST PHARMA COMPANIES EXPAND MARKET PRESENCE 139 8.6 MEDTECH COMPANIES 140 8.6.1 RISING DEMAND FOR ADVANCED TECHNOLOGIES FOR REMOTE DISEASE DIAGNOSIS AND TREATMENT TO FAVOR MARKET GROWTH 140 8.7 OTHER END USERS 141 9 AI IN REMOTE PATIENT MONITORING MARKET, BY REGION 142 9.1 INTRODUCTION 143 9.2 NORTH AMERICA 144 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 145 9.2.2 US 148 9.2.2.1 US to dominate North American market during study period 148 9.2.3 CANADA 151 9.2.3.1 Need to curtail healthcare costs and high penetration of smartphones and tablets to drive market 151 9.3 EUROPE 154 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 154 9.3.2 GERMANY 157 9.3.2.1 High healthcare expenditure and increased preference for home monitoring to propel market growth 157   9.3.3 UK 160 9.3.3.1 Favorable government initiatives and high demand for advanced healthcare solutions to aid market growth 160 9.3.4 FRANCE 163 9.3.4.1 Increased adoption of connected medical devices to fuel market growth 163 9.3.5 ITALY 166 9.3.5.1 Increased government health expenditure and high geriatric population to boost market growth 166 9.3.6 SPAIN 169 9.3.6.1 Need to reduce healthcare costs and improve treatment quality to drive adoption of AI-based remote patient monitoring devices 169 9.3.7 REST OF EUROPE 172 9.4 ASIA PACIFIC 175 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 176 9.4.2 CHINA 180 9.4.2.1 Strong internet access and high smartphone adoption to augment market growth 180 9.4.3 JAPAN 183 9.4.3.1 Rising geriatric population and increasing government health expenditure to aid market growth 183 9.4.4 INDIA 186 9.4.4.1 Need to bridge gap between rural patients and urban doctors to propel market growth 186 9.4.5 REST OF ASIA PACIFIC 189 9.5 LATIN AMERICA 191 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 191 9.5.2 BRAZIL 194 9.5.2.1 Favorable government initiatives and increased health expenditure to favor market growth 194 9.5.3 MEXICO 197 9.5.3.1 Technological advancements and favorable legal policies for digital health technologies to drive market 197 9.5.4 REST OF LATIN AMERICA 200 9.6 MIDDLE EAST & AFRICA 203 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 203 9.6.2 GCC COUNTRIES 206 9.6.2.1 Favorable government and non-government initiatives and increased investment in healthcare infrastructure to drive market 206 9.6.3 REST OF MIDDLE EAST & AFRICA 209   10 COMPETITIVE LANDSCAPE 213 10.1 INTRODUCTION 213 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 213 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS FOR AI IN REMOTE PATIENT MONITORING MARKET 214 10.3 REVENUE ANALYSIS, 2019–2023 216 10.4 MARKET SHARE ANALYSIS, 2023 217 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 220 10.5.1 STARS 220 10.5.2 EMERGING LEADERS 220 10.5.3 PERVASIVE PLAYERS 220 10.5.4 PARTICIPANTS 220 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 222 10.5.5.1 Company footprint 222 10.5.5.2 Region footprint 223 10.5.5.3 Component footprint 224 10.5.5.4 Indication footprint 225 10.5.5.5 End-user footprint 226 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 227 10.6.1 PROGRESSIVE COMPANIES 227 10.6.2 RESPONSIVE COMPANIES 227 10.6.3 DYNAMIC COMPANIES 227 10.6.4 STARTING BLOCKS 227 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 229 10.6.5.1 Detailed list of key startups/SMEs 229 10.6.5.2 Competitive benchmarking of key emerging players/startups 229 10.7 COMPANY VALUATION & FINANCIAL METRICS 230 10.7.1 FINANCIAL METRICS 230 10.7.2 COMPANY VALUATION 230 10.8 BRAND/SOFTWARE COMPARISON 231 10.9 COMPETITIVE SCENARIO 232 10.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 232 10.9.2 DEALS 233 10.9.3 EXPANSIONS 234 10.9.4 OTHER DEVELOPMENTS 234   11 COMPANY PROFILES 235 11.1 KEY PLAYERS 235 11.1.1 MEDTRONIC 235 11.1.1.1 Business overview 235 11.1.1.2 Products/Services/Solutions offered 236 11.1.1.3 Recent developments 238 11.1.1.3.1 Product approvals 238 11.1.1.3.2 Deals 238 11.1.1.4 MnM view 239 11.1.1.4.1 Right to win 239 11.1.1.4.2 Strategic choices 239 11.1.1.4.3 Weaknesses & competitive threats 239 11.1.2 KONINKLIJKE PHILIPS N.V. 240 11.1.2.1 Business overview 240 11.1.2.2 Products/Services/Solutions offered 241 11.1.2.3 Recent developments 243 11.1.2.3.1 Product launches & approvals 243 11.1.2.3.2 Deals 244 11.1.2.4 MnM view 246 11.1.2.4.1 Right to win 246 11.1.2.4.2 Strategic choices 246 11.1.2.4.3 Weaknesses & competitive threats 246 11.1.3 GE HEALTHCARE 247 11.1.3.1 Business overview 247 11.1.3.2 Products/Services/Solutions offered 248 11.1.3.3 Recent developments 249 11.1.3.3.1 Deals 249 11.1.3.4 MnM view 250 11.1.3.4.1 Right to win 250 11.1.3.4.2 Strategic choices 250 11.1.3.4.3 Weaknesses & competitive threats 250 11.1.4 BOSTON SCIENTIFIC CORPORATION 251 11.1.4.1 Business overview 251 11.1.4.2 Products/Services/Solutions offered 252 11.1.4.3 Recent developments 253 11.1.4.3.1 Product launches 253 11.1.4.3.2 Deals 254 11.1.4.3.3 Expansions 254 11.1.4.3.4 Other developments 255 11.1.4.4 MnM view 255 11.1.4.4.1 Right to win 255 11.1.4.4.2 Strategic choices 255 11.1.4.4.3 Weaknesses & competitive threats 255 11.1.5 OMRON HEALTHCARE, INC. 256 11.1.5.1 Business overview 256 11.1.5.2 Products/Services/Solutions offered 257 11.1.5.3 Recent developments 259 11.1.5.3.1 Product approvals & enhancements 259 11.1.5.3.2 Deals 259 11.1.5.4 MnM view 260 11.1.5.4.1 Right to win 260 11.1.5.4.2 Strategic choices 260 11.1.5.4.3 Weaknesses & competitive threats 260 11.1.6 RESMED, INC. 261 11.1.6.1 Business overview 261 11.1.6.2 Products/Services/Solutions offered 262 11.1.6.3 Recent developments 264 11.1.6.3.1 Product launches & enhancements 264 11.1.6.3.2 Deals 265 11.1.6.3.3 Expansions 265 11.1.6.3.4 Other developments 266 11.1.7 NIHON KOHDEN CORPORATION 267 11.1.7.1 Business overview 267 11.1.7.2 Products/Services/Solutions offered 268 11.1.7.3 Recent developments 271 11.1.7.3.1 Product launches & approvals 271 11.1.7.3.2 Deals 272 11.1.7.3.3 Other developments 272 11.1.8 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS) 273 11.1.8.1 Business overview 273 11.1.8.2 Products/Services/Solutions offered 274 11.1.8.3 Recent developments 275 11.1.8.3.1 Product launches & approvals 275 11.1.8.3.2 Deals 276 11.1.9 IRHYTHM INC. 277 11.1.9.1 Business overview 277 11.1.9.2 Products/Services/Solutions offered 278 11.1.9.3 Recent developments 279 11.1.9.3.1 Product launches & approvals 279 11.1.9.3.2 Deals 280 11.1.10 BEIJING CHOICE ELECTRONIC TECH CO., LTD. 281 11.1.10.1 Business overview 281 11.1.10.2 Products/Services/Solutions offered 281   11.1.11 BIOTRONIK 283 11.1.11.1 Business overview 283 11.1.11.2 Products/Services/Solutions offered 283 11.1.11.3 Recent developments 284 11.1.11.3.1 Product launches & approvals 284 11.1.11.3.2 Deals 284 11.1.12 ALIVECOR, INC. 285 11.1.12.1 Business overview 285 11.1.12.2 Products/Services/Solutions offered 285 11.1.12.3 Recent developments 286 11.1.12.3.1 Product launches & approvals 286 11.1.12.3.2 Deals 287 11.1.12.3.3 Other developments 288 11.1.13 MASIMO 289 11.1.13.1 Business overview 289 11.1.13.2 Products/Services/Solutions offered 290 11.1.13.3 Recent developments 291 11.1.13.3.1 Product approvals & enhancements 291 11.1.13.4 Recent developments 292 11.1.13.4.1 Deals 292 11.1.14 DEXCOM, INC. 293 11.1.14.1 Business overview 293 11.1.14.2 Products/Services/Solutions offered 294 11.1.14.3 Recent developments 295 11.1.14.3.1 Product launches & approvals 295 11.1.14.3.2 Deals 296 11.1.15 BIOBEAT 297 11.1.15.1 Business overview 297 11.1.15.2 Products/Services/Solutions offered 297 11.1.15.3 Recent developments 298 11.1.15.3.1 Product launches & approvals 298 11.1.15.3.2 Deals 299 11.1.16 TYTOCARE LTD. 301 11.1.16.1 Business overview 301 11.1.16.2 Products/Services/Solutions offered 301 11.1.16.3 Recent developments 302 11.1.16.3.1 Product enhancements 302 11.1.16.3.2 Deals 302 11.1.16.3.3 Other developments 302 11.1.17 ZETO INC. 303 11.1.17.1 Business overview 303 11.1.17.2 Products/Services/Solutions offered 303 11.1.18 GLOOKO, INC. 304 11.1.18.1 Business overview 304 11.1.18.2 Products/Services/Solutions offered 304 11.1.18.3 Recent developments 305 11.1.18.3.1 Product launches & enhancements 305 11.1.18.3.2 Deals 305 11.1.18.3.3 Other developments 306 11.1.19 WELLDOC, INC. 307 11.1.19.1 Business overview 307 11.1.19.2 Products/Services/Solutions offered 307 11.1.19.3 Recent developments 308 11.1.19.3.1 Product approvals & enhancements 308 11.1.19.3.2 Deals 308 11.1.20 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE) 310 11.1.20.1 Business overview 310 11.1.20.2 Products/Services/Solutions offered 310 11.1.20.3 Recent developments 311 11.1.20.3.1 Product approvals 311 11.1.20.3.2 Other developments 311 11.2 OTHER PLAYERS 312 11.2.1 BIOINTELLISENSE, INC. 312 11.2.2 BLUE SPARK TECHNOLOGIES, INC. 313 11.2.3 ACCURKARDIA, INC. 314 11.2.4 AION BIOSYSTEMS, INC. 314 11.2.5 BROOK INC. 315 12 APPENDIX 316 12.1 DISCUSSION GUIDE 316 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 320 12.3 CUSTOMIZATION OPTIONS 322 12.4 RELATED REPORTS 322 12.5 AUTHOR DETAILS 323
圖表清單 List of Tables & Figures
TABLE 1 AI IN REMOTE PATIENT MONITORING MARKET: INCLUSIONS & EXCLUSIONS 31 TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 32 TABLE 3 AI IN REMOTE PATIENT MONITORING MARKET: FACTOR ANALYSIS 45 TABLE 4 AI IN REMOTE PATIENT MONITORING MARKET: MARKET SIZING ASSUMPTIONS 49 TABLE 5 AI IN REMOTE PATIENT MONITORING MARKET: RISK ASSESSMENT 50 TABLE 6 AI IN REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59 TABLE 7 RECENT DEVELOPMENTS IN AI-BASED SOLUTIONS FOR REMOTE PATIENT MONITORING, JANUARY 2022–DECEMBER 2024 60 TABLE 8 AI IN REMOTE PATIENT MONITORING MARKET: ROLE IN ECOSYSTEM 71 TABLE 9 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9018 76 TABLE 10 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9021 77 TABLE 11 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9022 78 TABLE 12 REGULATORY SCENARIO OF NORTH AMERICA 79 TABLE 13 REGULATORY SCENARIO OF EUROPE 80 TABLE 14 REGULATORY SCENARIO OF ASIA PACIFIC 81 TABLE 15 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 82 TABLE 16 REGULATORY SCENARIO OF LATIN AMERICA 82 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 22 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND) 88 TABLE 23 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND) 88 TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND) 89 TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND) 89 TABLE 26 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND) 90 TABLE 27 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND) 90 TABLE 28 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023 91 TABLE 29 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023 93 TABLE 30 AI IN REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES 94 TABLE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%) 96 TABLE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS 97 TABLE 33 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS 98 TABLE 34 AI IN REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS 100 TABLE 35 AI IN REMOTE PATIENT MONITORING MARKET: UNMET NEEDS 102 TABLE 36 AI IN REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS 103 TABLE 37 AI IN REMOTE PATIENT MONITORING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 104 TABLE 38 CASE STUDY 1: ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING 105 TABLE 39 CASE STUDY 2: ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS 105 TABLE 40 CASE STUDY 2: ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY 106 TABLE 41 CPT CODES AND REIMBURSEMENT ANALYSIS FOR AI-BASED REMOTE PATIENT MONITORING DEVICES IN US 109 TABLE 42 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 112 TABLE 43 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 113 TABLE 44 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 113 TABLE 45 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (THOUSAND UNITS) 114 TABLE 46 AI IN REMOTE PATIENT MONITORING WEARABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 115 TABLE 47 AI IN REMOTE PATIENT MONITORING IMPLANTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 116 TABLE 48 AI IN REMOTE PATIENT MONITORING HANDHELD & PORTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 117 TABLE 49 AI IN REMOTE PATIENT MONITORING STATIONARY DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 118 TABLE 50 AI IN REMOTE PATIENT MONITORING SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 119 TABLE 51 AI IN REMOTE PATIENT MONITORING SERVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 120 TABLE 52 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 122 TABLE 53 AI IN REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2022–2030 (USD MILLION) 123 TABLE 54 AI IN REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2022–2030 (USD MILLION) 124 TABLE 55 AI IN REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2022–2030 (USD MILLION) 125 TABLE 56 AI IN REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2022–2030 (USD MILLION) 126 TABLE 57 AI IN REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2022–2030 (USD MILLION) 127 TABLE 58 AI IN REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022–2030 (USD MILLION) 128 TABLE 59 AI IN REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT, BY REGION, 2022–2030 (USD MILLION) 128 TABLE 60 AI IN REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2022–2030 (USD MILLION) 129 TABLE 61 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2022–2030 (USD MILLION) 130 TABLE 62 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 132 TABLE 63 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 133 TABLE 64 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 133 TABLE 65 AI IN REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION) 134 TABLE 66 AI IN REMOTE PATIENT MONITORING MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION) 135 TABLE 67 AI IN REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION) 136 TABLE 68 AI IN REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE FACILITIES, BY REGION, 2022–2030 (USD MILLION) 137 TABLE 69 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 137 TABLE 70 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION) 138 TABLE 71 AI IN REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION) 139 TABLE 72 AI IN REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION) 140 TABLE 73 AI IN REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION) 141 TABLE 74 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 141 TABLE 75 AI IN REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION) 143 TABLE 76 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 145 TABLE 77 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 145 TABLE 78 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 146 TABLE 79 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 146 TABLE 80 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 147 TABLE 81 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 147 TABLE 82 US: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 148 TABLE 83 US: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 149 TABLE 84 US: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 149 TABLE 85 US: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 150 TABLE 86 US: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 150 TABLE 87 CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 151 TABLE 88 CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 152 TABLE 89 CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY INDICATION, 2022–2030 (USD MILLION) 152 TABLE 90 CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 153 TABLE 91 CANADA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 153 TABLE 92 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 154 TABLE 93 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 155 TABLE 94 EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 155 TABLE 95 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 156 TABLE 96 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 156 TABLE 97 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 157 TABLE 98 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 158 TABLE 99 GERMANY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 158 TABLE 100 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 159 TABLE 101 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 159 TABLE 102 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 160 TABLE 103 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 161 TABLE 104 UK: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 161 TABLE 105 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 162 TABLE 106 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 162 TABLE 107 UK: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 163 TABLE 108 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 164 TABLE 109 FRANCE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 164 TABLE 110 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 165 TABLE 111 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 165 TABLE 112 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 166 TABLE 113 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 167 TABLE 114 ITALY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 167 TABLE 115 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 168 TABLE 116 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 168 TABLE 117 ITALY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 169 TABLE 118 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 170 TABLE 119 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 170 TABLE 120 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 171 TABLE 121 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 171 TABLE 122 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 172 TABLE 123 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 173 TABLE 124 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 173 TABLE 125 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 174 TABLE 126 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 174 TABLE 127 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 175 TABLE 128 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 177 TABLE 129 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 177 TABLE 130 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 178 TABLE 131 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 178 TABLE 132 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 179 TABLE 133 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 179 TABLE 134 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 180 TABLE 135 CHINA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 181 TABLE 136 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 181 TABLE 137 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 182 TABLE 138 CHINA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 182 TABLE 139 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 183 TABLE 140 JAPAN: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 184 TABLE 141 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 184 TABLE 142 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 185 TABLE 143 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 185 TABLE 144 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 186 TABLE 145 INDIA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 187 TABLE 146 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 187 TABLE 147 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 188 TABLE 148 INDIA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 188 TABLE 149 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 189 TABLE 150 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 189 TABLE 151 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 190 TABLE 152 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 190 TABLE 153 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 191 TABLE 154 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 192 TABLE 155 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 192 TABLE 156 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 192 TABLE 157 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 193 TABLE 158 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 193 TABLE 159 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 194 TABLE 160 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 194 TABLE 161 BRAZIL: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 195 TABLE 162 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 195 TABLE 163 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 196 TABLE 164 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 196 TABLE 165 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 197 TABLE 166 MEXICO: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 198 TABLE 167 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 198 TABLE 168 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 199 TABLE 169 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 199 TABLE 170 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 200 TABLE 171 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 201 TABLE 172 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 201 TABLE 173 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 202 TABLE 174 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 202 TABLE 175 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION) 204 TABLE 176 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 204 TABLE 177 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 204 TABLE 178 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 205 TABLE 179 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 205 TABLE 180 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 206 TABLE 181 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 207 TABLE 182 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 207 TABLE 183 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 208 TABLE 184 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 208 TABLE 185 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 209 TABLE 186 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 210 TABLE 187 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 210 TABLE 188 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 211 TABLE 189 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 211 TABLE 190 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 212 TABLE 191 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021–JANUARY 2025 214 TABLE 192 AI IN REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION 218 TABLE 193 AI IN REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT 223 TABLE 194 AI IN REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT 224 TABLE 195 AI IN REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT 225 TABLE 196 AI IN REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT 226 TABLE 197 AI IN REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 229 TABLE 198 AI IN REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 229 TABLE 199 AI IN REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–JANUARY 2025 232 TABLE 200 AI IN REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021–JANUARY 2025 233 TABLE 201 AI IN REMOTE PATIENT MONITORING MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 234 TABLE 202 AI IN REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 234 TABLE 203 MEDTRONIC: COMPANY OVERVIEW 235 TABLE 204 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 236 TABLE 205 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 238 TABLE 206 MEDTRONIC: DEALS, JANUARY 2021–JANUARY 2025 238 TABLE 207 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 240 TABLE 208 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 241 TABLE 209 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 243 TABLE 210 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–JANUARY 2025 244 TABLE 211 GE HEALTHCARE: COMPANY OVERVIEW 247 TABLE 212 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 248 TABLE 213 GE HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025 249 TABLE 214 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 251 TABLE 215 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 252 TABLE 216 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 253 TABLE 217 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 254 TABLE 218 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025 254 TABLE 219 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 255 TABLE 220 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW 256 TABLE 221 OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 257 TABLE 222 OMRON HEALTHCARE, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 259 TABLE 223 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021–JANUARY 2025 259 TABLE 224 RESMED, INC.: COMPANY OVERVIEW 261 TABLE 225 RESMED, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 262 TABLE 226 RESMED, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 264 TABLE 227 RESMED, INC.: DEALS, JANUARY 2021–JANUARY 2025 265 TABLE 228 RESMED, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025 265 TABLE 229 RESMED, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 266 TABLE 230 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 267 TABLE 231 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 268 TABLE 232 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 271 TABLE 233 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 272 TABLE 234 NIHON KOHDEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 272 TABLE 235 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY OVERVIEW 273 TABLE 236 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCTS/SERVICES/SOLUTIONS OFFERED 274 TABLE 237 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 275 TABLE 238 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): DEALS, JANUARY 2021–JANUARY 2025 276 TABLE 239 IRHYTHM INC.: COMPANY OVERVIEW 277 TABLE 240 IRHYTHM INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 278 TABLE 241 IRHYTHM INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 279 TABLE 242 IRHYTHM INC.: DEALS, JANUARY 2021–JANUARY 2025 280 TABLE 243 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: COMPANY OVERVIEW 281 TABLE 244 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 281 TABLE 245 BIOTRONIK: COMPANY OVERVIEW 283 TABLE 246 BIOTRONIK: PRODUCTS/SERVICES/SOLUTIONS OFFERED 283 TABLE 247 BIOTRONIK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 284 TABLE 248 BIOTRONIK: DEALS, JANUARY 2021–JANUARY 2025 284 TABLE 249 ALIVECOR, INC.: COMPANY OVERVIEW 285 TABLE 250 ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 285 TABLE 251 ALIVECOR, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 286 TABLE 252 ALIVECOR, INC.: DEALS, JANUARY 2021–JANUARY 2025 287 TABLE 253 ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 288 TABLE 254 MASIMO: COMPANY OVERVIEW 289 TABLE 255 MASIMO: PRODUCTS/SERVICES/SOLUTIONS OFFERED 290 TABLE 256 MASIMO: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 291 TABLE 257 MASIMO: DEALS, JANUARY 2021–JANUARY 2025 292 TABLE 258 DEXCOM, INC.: COMPANY OVERVIEW 293 TABLE 259 DEXCOM, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 294 TABLE 260 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 295 TABLE 261 DEXCOM, INC.: DEALS, JANUARY 2021–JANUARY 2025 296 TABLE 262 BIOBEAT: COMPANY OVERVIEW 297 TABLE 263 BIOBEAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 297 TABLE 264 BIOBEAT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 298 TABLE 265 BIOBEAT: DEALS, JANUARY 2021–JANUARY 2025 299 TABLE 266 TYTOCARE LTD.: COMPANY OVERVIEW 301 TABLE 267 TYTOCARE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 301 TABLE 268 TYTOCARE LTD.: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025 302 TABLE 269 TYTOCARE LTD.: DEALS, JANUARY 2021–JANUARY 2025 302 TABLE 270 TYTOCARE LTD.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 302 TABLE 271 ZETO INC.: COMPANY OVERVIEW 303 TABLE 272 ZETO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 303 TABLE 273 GLOOKO, INC.: COMPANY OVERVIEW 304 TABLE 274 GLOOKO, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 304 TABLE 275 GLOOKO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 305 TABLE 276 GLOOKO, INC.: DEALS, JANUARY 2021–JANUARY 2025 305 TABLE 277 GLOOKO, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 306 TABLE 278 WELLDOC, INC.: COMPANY OVERVIEW 307 TABLE 279 WELLDOC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 307 TABLE 280 WELLDOC, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 308 TABLE 281 WELLDOC, INC.: DEALS, JANUARY 2021–JANUARY 2025 308 TABLE 282 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): COMPANY OVERVIEW 310 TABLE 283 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCTS/SERVICES/ SOLUTIONS OFFERED 310 TABLE 284 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 311 TABLE 285 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 311 TABLE 286 BIOINTELLISENSE, INC.: COMPANY OVERVIEW 312 TABLE 287 BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW 313 TABLE 288 ACCURKARDIA, INC.: COMPANY OVERVIEW 314 TABLE 289 AION BIOSYSTEMS, INC.: COMPANY OVERVIEW 314 TABLE 290 BROOK INC.: COMPANY OVERVIEW 315 _ FIGURE 1 AI IN REMOTE PATIENT MONITORING MARKET SEGMENTATION & GEOGRAPHICAL SPREAD 30 FIGURE 2 AI IN REMOTE PATIENT MONITORING MARKET: YEARS CONSIDERED 32 FIGURE 3 AI IN REMOTE PATIENT MONITORING MARKET: RESEARCH DESIGN 34 FIGURE 4 AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM SECONDARY SOURCES 35 FIGURE 5 AI IN REMOTE PATIENT MONITORING MARKET: KEY PRIMARY SOURCES 36 FIGURE 6 AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM PRIMARY SOURCES 37 FIGURE 7 AI IN REMOTE PATIENT MONITORING MARKET: INSIGHTS FROM PRIMARIES 38 FIGURE 8 BREAKDOWN OF PRIMARY SOURCES: BY COMPANY TYPE, DESIGNATION, AND REGION 39 FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40 FIGURE 10 AI IN REMOTE PATIENT MONITORING MARKET: SUPPLY-SIDE MARKET ESTIMATION 41 FIGURE 11 AI IN REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH FOR OMRON HEALTHCARE, INC. (2023) 42 FIGURE 12 BOTTOM-UP APPROACH: END-USER SPENDING ON AI-BASED REMOTE PATIENT MONITORING SOLUTIONS 43 FIGURE 13 AI IN REMOTE PATIENT MONITORING MARKET: TOP-DOWN APPROACH 44 FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030) 46 FIGURE 15 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47 FIGURE 16 AI IN REMOTE PATIENT MONITORING MARKET: DATA TRIANGULATION 48 FIGURE 17 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION) 51 FIGURE 18 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION) 52 FIGURE 19 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 53 FIGURE 20 AI IN REMOTE PATIENT MONITORING MARKET: REGIONAL SNAPSHOT 54 FIGURE 21 IMPROVED MEDICAL INFRASTRUCTURE AND COST BENEFITS OF REMOTE HEALTH MONITORING TO DRIVE MARKET 55 FIGURE 22 US AND HEALTHCARE PROVIDERS TO COMMAND LARGEST NORTH AMERICAN MARKET SHARE IN 2023 56 FIGURE 23 INDIA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030 57 FIGURE 24 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 57 FIGURE 25 AI IN REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58 FIGURE 26 US MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024 64 FIGURE 27 AI IN REMOTE PATIENT MONITORING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 68 FIGURE 28 AI IN REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS 70 FIGURE 29 AI IN REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS 72 FIGURE 30 AVERAGE SELLING PRICE FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY TYPE (2023) 92 FIGURE 31 AI IN REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 94 FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 96 FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS 97 FIGURE 34 PATENT PUBLICATION TRENDS IN AI IN REMOTE PATIENT MONITORING MARKET, 2015–2024 98 FIGURE 35 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS (JANUARY 2015–DECEMBER 2024) 98 FIGURE 36 TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015–DECEMBER 2024) 99 FIGURE 37 AI IN REMOTE PATIENT MONITORING MARKET: FUNDING AND NUMBER OF DEALS, 2022–2024 107 FIGURE 38 US: PERCENTAGE OF NEW CANCER CASES (2024) 123 FIGURE 39 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT 144 FIGURE 40 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT 176 FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, 2019–2023 (USD MILLION) 216 FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET (2023) 217 FIGURE 43 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 221 FIGURE 44 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT 222 FIGURE 45 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 228 FIGURE 46 EV/EBITDA OF KEY VENDORS 230 FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 230 FIGURE 48 AI IN REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 231 FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT 236 FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 241 FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT 248 FIGURE 52 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 252 FIGURE 53 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT 257 FIGURE 54 RESMED, INC.: COMPANY SNAPSHOT 262 FIGURE 55 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 268 FIGURE 56 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY SNAPSHOT 274 FIGURE 57 IRHYTHM INC.: COMPANY SNAPSHOT 277 FIGURE 58 MASIMO: COMPANY SNAPSHOT 290 FIGURE 59 DEXCOM, INC.: COMPANY SNAPSHOT 294

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們